nsclc

Pick anything below and it plays in the bar at the foot of the window — and keeps playing while you go on browsing the directory.

1. 1▶IberdomideOncoPharm15:37Notes
   +Listen later
2. 2▶LCC: Grace Under Pressure: Navigating Burnout and Loss in OncologyLung Cancer Considered47:14Notes
   +Listen later
3. 3▶Amarnath Challapalli, MBBS, MD (RT), MRCP, FRCR, PhD, FRCP / Amer Durrani, FRCS (Plast) - Partnering With Patients in High-Risk CSCC: Redefining the Surgical Paradigm to Optimise Clinical and Patient OutcomesPeerVoice Oncology & Haematology Video32:12Notes
   +Watch later
4. 4▶LCC Advances in ALK+ Cancer in CantoneseLung Cancer Considered46:26Notes
   +Listen later
5. 5▶Kidney Cancer in a NutshellOncoPharm16:12Notes
   +Listen later
6. 6▶Meletios Dimopoulos, MD - Individualisation Requires Communication: Working With Our Patients With Newly Diagnosed Multiple Myeloma (NDMM) to Optimise Treatment OutcomesPeerVoice Oncology & Haematology Video1:20:49Notes
   +Watch later
7. 7▶Small Cell Lung Cancer and CINV UpdatesOncoPharm17:35Notes
   +Listen later
8. 8▶Treating Advanced Thymic CancersLung Cancer Considered59:23Notes
   +Listen later
9. 9▶Zidesamtinib & PPIs in PacificOncoPharm16:32Notes
   +Listen later
10. 10▶FDA Approval: Zidesamtinib and ROS1 NSCLCLung Cancer Considered24:01Notes
    +Listen later
11. 11▶Gedatolisib et alOncoPharm18:16Notes
    +Listen later
12. 12▶Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung CancerLung Cancer Considered47:39Notes
    +Listen later
13. 13▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Oncology & Haematology Video26:33Notes
    +Watch later
14. 14▶Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and ManagementPeerVoice Heart & Lung Audio16:39Notes
    +Listen later
15. 15▶Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and ManagementPeerVoice Heart & Lung Video16:39Notes
    +Watch later
16. 16▶Endurance Part 2OncoPharm15:12Notes
    +Listen later
17. 17▶A Decade of CAR-T, Ocra-T, & POLARGOOncoPharm19:18Notes
    +Listen later
18. 18▶IASLC - Your First Faculty JobLung Cancer Considered41:58Notes
    +Listen later
19. 19▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Heart & Lung Audio1:17:14Notes
    +Listen later
20. 20▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Heart & Lung Video1:17:14Notes
    +Watch later
21. 21▶Breast Cancer Updates and T-Cell StemnessOncoPharm19:23Notes
    +Listen later
22. 22▶Game Changers & Hard Truths: Dr. Balazs Halmos UnfilteredLung Cancer Considered45:54Notes
    +Listen later
23. 23▶Updates on capivasertib, belzutifan, talquetamab, & durvalumabOncoPharm19:32Notes
    +Listen later
24. 24▶Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) PreviewLung Cancer Considered39:16Notes
    +Listen later
25. 25▶ASCO '26OncoPharm25:38Notes
    +Listen later
26. 26▶Andrea Necchi, MD - Working With Our Patients as a Member of the MDT: A Bladder Cancer Awareness Month 2026 CME InitiativePeerVoice Oncology & Haematology Video21:06Notes
    +Watch later
27. 27▶ASCO 2026 Highlights – Part 2: Emerging Immunotherapy Strategies in Lung CancerLung Cancer Considered40:18Notes
    +Listen later
28. 28▶Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances EmergePeerVoice Oncology & Haematology Video18:45Notes
    +Watch later
29. 29▶Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast CancerPeerVoice Oncology & Haematology Video19:41Notes
    +Watch later
30. 30▶ASCO 2026 Highlights – Part 1: Landmark Advances in Targeted TherapyLung Cancer Considered45:54Notes
    +Listen later
31. 31▶Marwan Fakih, MD - Making a Difference in Refractory Metastatic Colorectal Cancer: Practical Strategies to Positively Impact the Patient Journey Across Practice SettingsPeerVoice Oncology & Haematology Video28:23Notes
    +Watch later
32. 32▶Trisha Wise-Draper, MD, PhD - Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck CancerPeerVoice Oncology & Haematology Video54:23Notes
    +Watch later
33. 33▶Martin Köbel, MD - Scoring Folate Receptor-Alpha Expression in Gynecological Cancers: An Interactive Pathology MasterclassPeerVoice Oncology & Haematology Video29:59Notes
    +Watch later
34. 34▶Anjali Tiku Owens, MD - Contemporary Data, Differentiation, and Decision-Making in Hypertrophic Cardiomyopathy: A Guide to Cardiac Myosin Inhibition for the Managed Care ProfessionalPeerVoice Heart & Lung Audio1:20:09Notes
    +Listen later
35. 35▶Anjali Tiku Owens, MD - Contemporary Data, Differentiation, and Decision-Making in Hypertrophic Cardiomyopathy: A Guide to Cardiac Myosin Inhibition for the Managed Care ProfessionalPeerVoice Heart & Lung Video1:20:09Notes
    +Watch later
36. 36▶Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa InhibitionPeerVoice Heart & Lung Audio36:53Notes
    +Listen later
37. 37▶Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa InhibitionPeerVoice Heart & Lung Video36:53Notes
    +Watch later
38. 38▶Pier Luigi Zinzani, MD, PhD - Recognising and Responding to a Rare Disease: A Case-Based Exploration of the Ideal iMCD Patient JourneyPeerVoice Oncology & Haematology Video20:07Notes
    +Watch later
39. 39▶Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy EraPeerVoice Heart & Lung Audio40:01Notes
    +Listen later
40. 40▶Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy EraPeerVoice Heart & Lung Video40:01Notes
    +Watch later
41. 41▶Louise Moist, MD, MSc, CCPE / Peter J. Lin, MD, CCFP - Managing CKD With SGLT2 Inhibitors in Primary Care: Applying New Evidence Into Clinical PracticePeerVoice Heart & Lung Video14:00Notes
    +Watch later
42. 42▶Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established TherapiesPeerVoice Heart & Lung Audio21:52Notes
    +Listen later
43. 43▶Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established TherapiesPeerVoice Heart & Lung Video21:51Notes
    +Watch later
44. 44▶Ira Goldberg, MD - Mastering the Fundamentals of Care for Chylomicronemia: Following the Patient Care Pathway From Differential Diagnosis to Modern ManagementPeerVoice Heart & Lung Audio29:06Notes
    +Listen later
45. 45▶Ira Goldberg, MD - Mastering the Fundamentals of Care for Chylomicronemia: Following the Patient Care Pathway From Differential Diagnosis to Modern ManagementPeerVoice Heart & Lung Video29:06Notes
    +Watch later
46. 46▶Ira Goldberg, MD - The Expanding Treatment Landscape for Familial Chylomicronemia Syndrome: Exploring New Options and OpportunitiesPeerVoice Heart & Lung Audio9:49Notes
    +Listen later
47. 47▶Ira Goldberg, MD - The Expanding Treatment Landscape for Familial Chylomicronemia Syndrome: Exploring New Options and OpportunitiesPeerVoice Heart & Lung Video9:49Notes
    +Watch later
48. 48▶John E. Anderson, MD / Richard J. Auchus, MD, PhD - Hypercortisolism and Difficult-to-Treat Cardiometabolic Disease: Therapeutic Developments and Clinical Advances Driving Meaningful Improvement in Patient OutcomesPeerVoice Heart & Lung Audio30:19Notes
    +Listen later
49. 49▶John E. Anderson, MD / Richard J. Auchus, MD, PhD - Hypercortisolism and Difficult-to-Treat Cardiometabolic Disease: Therapeutic Developments and Clinical Advances Driving Meaningful Improvement in Patient OutcomesPeerVoice Heart & Lung Video30:19Notes
    +Watch later
50. 50▶Erwan Donal, MD, PhD / Nina Ajmone Marsan, MD, PhD - At the Cutting Edge of ATTR-CM: How Can We Leverage Advances in Multimodality Cardiac Imaging and Artificial Intelligence to Modernise Diagnosis and Monitoring?PeerVoice Heart & Lung Audio29:14Notes
    +Listen later